Want to see SKHHY full AI Analyst Report?
SKHHY Stock Chart & Stats
$14.46
$0.03(0.20%)
At close: 4:00 PM EDT
$14.46
$0.03(0.20%)
Day’s Range― - ―
52-Week Range$13.06 - $16.98
Previous CloseN/A
Volume148.47K
Average Volume (3M)56.13K
Market Cap
$6.43B
Enterprise Value$10.83K
Total Cash (Recent Filing)$653.73M
Total Debt (Recent Filing)$5.84B
Price to Earnings (P/E)15.1
Beta0.46
Next Earnings
Feb 22, 2027EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend Yield5.81%
Share Statistics
EPS (TTM)1.23
Shares Outstanding494,237,950
10 Day Avg. Volume13,315
30 Day Avg. Volume56,135
Financial Highlights & Ratios
PEG Ratio1.43
Price to Book (P/B)1.24
Price to Sales (P/S)0.96
P/FCF Ratio13.61
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.88
Revenue Forecast (FY)$7.93B
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Profit GrowthBroad-based growth across revenue, EBITDA, net profit and EPS indicates that Sonic is converting increased diagnostic demand into improved earnings. This strengthens internal funding capacity and supports continued investment in laboratories, imaging, advanced diagnostics and technology over the next several quarters.
Organic Growth And Advanced Diagnostics MomentumPositive organic growth and rising specialist referrals demonstrate underlying customer demand beyond acquisitions. Expansion in advanced diagnostics also supports a more differentiated service mix, potentially improving clinical relevance, customer retention and longer-term growth opportunities across Sonic’s geographic network.
M&A Integration And Operational ImprovementEarly synergy capture from LADR and concrete U.S. restructuring actions show that management is actively extracting value from its acquisition platform. Successful integration can expand scale, improve productivity and create a durable earnings contribution as remaining initiatives are implemented.
Bears Say
Margin Compression And Weaker ReturnsProfitability has not kept pace with the company’s recent revenue momentum, as margins remain materially below earlier peak levels and returns on equity have weakened. This limits operating leverage and leaves less earnings cushion if reimbursement, labor or other operating costs remain elevated.
Inconsistent Cash ConversionPositive cash generation is offset by uneven conversion from reported earnings into operating and free cash flow. Sustained variability can constrain internally funded expansion, increase reliance on financing for acquisitions or capital spending, and reduce confidence in the consistency of distributable cash.
Regulatory And Labor-cost PressureReimbursement and labor-cost changes create structural pressure on revenue and margins across several operating regions. Mitigation through synergies and productivity may take time, so these pressures could limit earnings growth and make future profitability more dependent on execution and cost discipline.
Sonic Healthcare News
SKHHY FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest stock price was $13.06 and its highest was $16.98 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is $6.43B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Feb 22, 2027 which is in 144 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Aug 19, 2026. The company reported $0.513 earnings per share for the quarter, beating the consensus estimate of $0.462 by $0.051.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Overvalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of $0.447 which represents an annual dividend yield of 5.81%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.38.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of $0.513 in its last earnings report, beating expectations of $0.462. Following the earnings report the stock price went down -9.213%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in SKHHY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.43%
12-Months-Change
Fundamentals
Return on Equity
5.81%
Trailing 12-Months
Asset Growth
10.50%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sonic Healthcare Limited
Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.
SKHHY Company Deck
SKHHY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive performance picture: strong revenue, EBITDA and NPAT growth, solid organic expansion, and notable success in advanced diagnostics and M&A integration (notably Germany and Switzerland). Management also outlined proactive investments in digital transformation and clear U.S. turnaround actions expected to deliver AUD 25–30 million in FY2027 earnings. However, several near-term headwinds were emphasized, including regulatory fee cuts in Switzerland (CHF 20m), U.K. contract integration delays, software impairments and legacy IT write-downs, higher interest and capex in FY2026, FX and policy uncertainties (PAMA, GOÄ). On balance the highlights (growth, synergy capture, digital investment and disciplined capital management) outweigh the lowlights, although they limit near-term upside and keep guidance conservative.View all SKHHY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors